138 related articles for article (PubMed ID: 2488105)
1. Hemodynamic effects of SIN-1 in acute left heart failure.
Ibrahim TM; Unger PH; Sobolski J; Depelchin P; Jottrand M; Degre S
Cardiovasc Drugs Ther; 1989 Aug; 3(4):557-61. PubMed ID: 2488105
[TBL] [Abstract][Full Text] [Related]
2. [Acute hemodynamic effects of SIN-1 and isosorbide dinitrate in stable left ventricular failure: a comparative double-blind, cross-over study].
Himbert D; Spreux-Varoquaux O; Jaeger P; Himbert C; Cohen-Solal A; Advenier C; Gourgon R
Ann Cardiol Angeiol (Paris); 1992 Oct; 41(8):455-62. PubMed ID: 1298186
[TBL] [Abstract][Full Text] [Related]
3. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
4. Effects of nitric oxide donor SIN-1 on oxygen availability and regional blood flow during endotoxic shock.
Zhang H; Rogiers P; Friedman G; Preiser JC; Spapen H; Buurman WA; Vincent JL
Arch Surg; 1996 Jul; 131(7):767-74. PubMed ID: 8678780
[TBL] [Abstract][Full Text] [Related]
5. Dose-effect relationships of prostaglandin E1 in severe endstage chronic heart failure.
Stanek B; Pacher R
Jpn Heart J; 1997 Jan; 38(1):53-65. PubMed ID: 9186281
[TBL] [Abstract][Full Text] [Related]
6. Infusions with molsidomine and isosorbide-5-mononitrate in congestive heart failure: mechanisms underlying attenuation of effects.
Lehmann G; Hähnel I; Reiniger G; Lampen M; Beyerle A; Schömig A
J Cardiovasc Pharmacol; 1998 Feb; 31(2):212-20. PubMed ID: 9475262
[TBL] [Abstract][Full Text] [Related]
7. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.
Lapp H; Mitrovic V; Franz N; Heuer H; Buerke M; Wolfertz J; Mueck W; Unger S; Wensing G; Frey R
Circulation; 2009 Jun; 119(21):2781-8. PubMed ID: 19451356
[TBL] [Abstract][Full Text] [Related]
8. Differential hemodynamic effects of the nitric oxide donor pirsidomine in comparison to SIN-1, nitroprusside and nitroglycerin.
Arkonac BM; Kersten JR; Wynsen JC; Nijhawan N; Warltier DC
Pharmacology; 1996 Feb; 52(2):92-100. PubMed ID: 8851630
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of molsidomine in patients with heart failure following acute myocardial infarction.
Cantelli I; Lolli C; Brunelli A; Bracchetti D
Am Heart J; 1985 Mar; 109(3 Pt 2):716-9. PubMed ID: 3838410
[TBL] [Abstract][Full Text] [Related]
10. Effects of molsidomine on hemodynamics and blood gases in acute myocardial infarction with left heart failure.
Renard M; Jacobs P; Liebens I; Friart A; Bernard R
Am Heart J; 1985 Mar; 109(3 Pt 2):720-2. PubMed ID: 3919551
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide.
Lepore JJ; Maroo A; Bigatello LM; Dec GW; Zapol WM; Bloch KD; Semigran MJ
Chest; 2005 May; 127(5):1647-53. PubMed ID: 15888841
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamics, tolerability, and pharmacokinetics of linsidomine (SIN-1) infusion during the acute phase of uncomplicated myocardial infarction.
Foucher-Lavergne A; Kolsky H; Spreux-Varoquaux O; Delonca J; Beaufils P
J Cardiovasc Pharmacol; 1993 Dec; 22(6):779-84. PubMed ID: 7509893
[TBL] [Abstract][Full Text] [Related]
13. [Hemodynamic and clinical effects and treatment tolerance with low-dose iv amrinone in patients with refractory heart failure: a multicenter study. The Group for Research on Amrinone in the Treatment of Refractory Heart Failure].
Dei Cas L; Metra M; Nodari S; Raddino R; Visioli O
Cardiologia; 1991 May; 36(5):363-71. PubMed ID: 1756541
[TBL] [Abstract][Full Text] [Related]
14. The influence of molsidomine on the hemodynamics of patients with chronic heart failure at rest and during exercise.
Larbig DT; Milstrey HR; Nasse H; Kahle T
Am Heart J; 1985 Mar; 109(3 Pt 2):688-90. PubMed ID: 3883738
[TBL] [Abstract][Full Text] [Related]
15. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
[TBL] [Abstract][Full Text] [Related]
16. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
Capomolla S; Pozzoli M; Opasich C; Febo O; Riccardi G; Salvucci F; Maestri R; Sisti M; Cobelli F; Tavazzi L
Am Heart J; 1997 Dec; 134(6):1089-98. PubMed ID: 9424070
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical and hemodynamic results of molsidomine treatment in patients with refractory heart failure.
Acar J; Kulas A; Escudier B
Am Heart J; 1985 Mar; 109(3 Pt 2):685-7. PubMed ID: 3883737
[TBL] [Abstract][Full Text] [Related]
18. Short-term intravenous sodium nitrite infusion improves cardiac and pulmonary hemodynamics in heart failure patients.
Ormerod JO; Arif S; Mukadam M; Evans JD; Beadle R; Fernandez BO; Bonser RS; Feelisch M; Madhani M; Frenneaux MP
Circ Heart Fail; 2015 May; 8(3):565-71. PubMed ID: 25838311
[TBL] [Abstract][Full Text] [Related]
19. Assessment of inotropic and vasodilating effects of milrinone lactate in patients with dilated cardiomyopathy and severe heart failure.
Bregagnollo EA; Fortes AH; Cicogna AC
Arq Bras Cardiol; 1999 Feb; 72(2):149-60. PubMed ID: 10488574
[TBL] [Abstract][Full Text] [Related]
20. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
